Darapladib
Darapladib Uses, Dosage, Side Effects, Food Interaction and all others data.
Trade Name | Darapladib |
Generic | Darapladib |
Darapladib Other Names | Darapladib |
Type | |
Formula | C36H38F4N4O2S |
Weight | Average: 666.78 Monoisotopic: 666.265160306 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in atherosclerosis.
How Darapladib works
Darapladib is a selective lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2 is an enzymatic upstream mediator of inflammatory processes. Evidence from experimental settings show that the breakdown products from oxidized low density lipoprotein C (LDL-C)such as lysophosphatidylcholine species and oxidized nonesterified fatty acids are pro-inflammatory and pro-apoptotic. These products are suspected to cause athlerosclerosis progression and plaque vulnerability, which leads to increased risk of cardiovascular problems.
Innovators Monograph
You find simplified version here Darapladib